Citigroup’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Citigroup's RMD Position: Q2 2026 in Review
Citigroup increased its ResMed (RMD) stake by 99% in Q2 2026, buying an estimated $79.7M and bringing the position to 774,425 shares worth $151M. The position accounts for 0.05% of the portfolio, ranked #330.
Citigroup first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Citigroup held 774,425 shares of ResMed worth $151M as of Q2 2026.
- Citigroup bought 384,343 ResMed shares in Q2 2026, an estimated $79.7M.
- ResMed made up 0.05% of Citigroup's portfolio in Q2 2026, its #330 holding.
- Citigroup first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.